Livzon Pharmaceutical Group Inc. (HKG:1513)
Hong Kong
· Delayed Price · Currency is HKD 29.35
+0.55 (1.91%)
Jun 27, 2025, 4:08 PM HKT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Chemical Agents | 6.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chemical Agents Growth | -6.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APIs and Intermediates | 3.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APIs and Intermediates Growth | 3.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Traditional Chinese Medicine | 1.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Traditional Chinese Medicine Growth | 39.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostic Reagents and Equipment | 658.97M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostic Reagents and Equipment Growth | -8.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biological | 84.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biological Growth | -79.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | 49.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | 18.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales Materials, Processing Fees, Etc. | 45.95M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rental | 9.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 13.67M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 96.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales Materials | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales Materials Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Processing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Processing Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Power Supply | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Power Supply Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Technology Transfer | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Gastrointestinal | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Gastrointestinal Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bulk Medicines and Intermediates | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bulk Medicines and Intermediates Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Gonadotropic Hormones | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Gonadotropic Hormones Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Antibiotics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Antibiotics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Cardio-cerebral Vascular | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Cardio-cerebral Vascular Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 10.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -1.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas | 1.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | 0.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|